Fidson Healthcare Plc (NGX:FIDSON)
Nigeria
· Delayed Price · Currency is NGN 22.00
+1.00 (4.76%)
At close: Apr 30, 2025
Fidson Healthcare Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 100,320 | 84,189 | 53,050 | 40,634 | 30,861 | 18,276 | Upgrade
|
| Revenue Growth (YoY) | 65.73% | 58.70% | 30.56% | 31.67% | 68.86% | 29.97% | Upgrade
|
| Cost of Revenue | 60,968 | 49,731 | 32,260 | 23,667 | 16,061 | 10,047 | Upgrade
|
| Gross Profit | 39,352 | 34,458 | 20,790 | 16,967 | 14,800 | 8,229 | Upgrade
|
| Selling, General & Admin | 18,783 | 16,186 | 11,802 | 9,583 | 9,534 | 5,481 | Upgrade
|
| Other Operating Expenses | -681.23 | -610.97 | -488.78 | -783.26 | -513.29 | -340.96 | Upgrade
|
| Operating Expenses | 18,603 | 15,876 | 11,541 | 8,754 | 9,021 | 5,140 | Upgrade
|
| Operating Income | 20,749 | 18,582 | 9,249 | 8,213 | 5,779 | 3,089 | Upgrade
|
| Interest Expense | -6,413 | -5,494 | -2,102 | -1,773 | -1,222 | -1,334 | Upgrade
|
| Interest & Investment Income | 60.02 | 60.02 | 23.01 | 65.42 | 77.72 | 9.24 | Upgrade
|
| Currency Exchange Gain (Loss) | -3,422 | -5,449 | -1,261 | -758.6 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 29.15 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 11,004 | 7,700 | 5,909 | 5,747 | 4,634 | 1,764 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.91 | 0.91 | 8.29 | 34.23 | 83.26 | 8.79 | Upgrade
|
| Pretax Income | 11,005 | 7,700 | 5,917 | 5,781 | 4,718 | 1,773 | Upgrade
|
| Income Tax Expense | 3,011 | 1,921 | 2,310 | 1,594 | 997.73 | 567.76 | Upgrade
|
| Net Income | 7,993 | 5,779 | 3,608 | 4,187 | 3,720 | 1,205 | Upgrade
|
| Net Income to Common | 7,993 | 5,779 | 3,608 | 4,187 | 3,720 | 1,205 | Upgrade
|
| Net Income Growth | 143.45% | 60.20% | -13.84% | 12.56% | 208.70% | 195.94% | Upgrade
|
| Shares Outstanding (Basic) | 2,291 | 2,295 | 2,295 | 2,295 | 2,295 | 2,295 | Upgrade
|
| Shares Outstanding (Diluted) | 2,291 | 2,295 | 2,295 | 2,295 | 2,295 | 2,295 | Upgrade
|
| Shares Change (YoY) | -0.13% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 3.49 | 2.52 | 1.57 | 1.82 | 1.62 | 0.53 | Upgrade
|
| EPS (Diluted) | 3.49 | 2.52 | 1.57 | 1.82 | 1.62 | 0.53 | Upgrade
|
| EPS Growth | 143.77% | 60.20% | -13.84% | 12.56% | 208.70% | 195.94% | Upgrade
|
| Free Cash Flow | 4,940 | -4,198 | -2,898 | -2,873 | 2,234 | 897.42 | Upgrade
|
| Free Cash Flow Per Share | 2.16 | -1.83 | -1.26 | -1.25 | 0.97 | 0.39 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 0.600 | 0.550 | 0.455 | 0.227 | Upgrade
|
| Dividend Growth | 66.67% | 66.67% | 9.09% | 21.01% | 99.96% | 66.64% | Upgrade
|
| Gross Margin | 39.23% | 40.93% | 39.19% | 41.76% | 47.96% | 45.03% | Upgrade
|
| Operating Margin | 20.68% | 22.07% | 17.44% | 20.21% | 18.73% | 16.90% | Upgrade
|
| Profit Margin | 7.97% | 6.87% | 6.80% | 10.30% | 12.05% | 6.59% | Upgrade
|
| Free Cash Flow Margin | 4.92% | -4.99% | -5.46% | -7.07% | 7.24% | 4.91% | Upgrade
|
| EBITDA | 22,493 | 20,215 | 10,458 | 9,110 | 6,474 | 3,796 | Upgrade
|
| EBITDA Margin | 22.42% | 24.01% | 19.71% | 22.42% | 20.98% | 20.77% | Upgrade
|
| D&A For EBITDA | 1,744 | 1,632 | 1,209 | 897.42 | 695.39 | 707.12 | Upgrade
|
| EBIT | 20,749 | 18,582 | 9,249 | 8,213 | 5,779 | 3,089 | Upgrade
|
| EBIT Margin | 20.68% | 22.07% | 17.44% | 20.21% | 18.73% | 16.90% | Upgrade
|
| Effective Tax Rate | 27.37% | 24.95% | 39.03% | 27.58% | 21.15% | 32.03% | Upgrade
|
| Advertising Expenses | - | 626.93 | 1,183 | 1,400 | 663.26 | 340.99 | Upgrade
|
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.